Clinical TrialID 2792

Clinical Trial of Lupeol for Mild-moderate Acne

NCT02152865

Acne

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2792
Evidence Id
2792
Core Evidence Id
2792
Source Clinical Trial Id
2764
Herb2 Clinical Trial Id
HBCT002764
Nct Id
NCT02152865
Title
Clinical Trial of Lupeol for Mild-moderate Acne
Status
Completed
Phase
Study Result
No
Study Condition
Acne
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Lupeol|DRUG: Control vehicle
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
25
Outcome Measure
Acne lesion counts as a measure of efficacy, Both inflammatory \& non-inflammatory acne lesions of both of their facial sides, 8 weeks after beginning of applications
Sponsor Collaborator
Seoul National University Hospital
Funded By
OTHER
Location
Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
Other Id
anti-acne product
Start Date
2009-12
Primary Completion Date
2014-05
Completion Date
2014-05
First Posted
2014-06-02
Results First Posted
Last Update Posted
2014-06-02
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02152865
Title Cn
Title En
Clinical Trial of Lupeol for Mild-moderate Acne
Bilingual Status
semi_complete